We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
PeriodicalsMedical Sciences

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

Checking your access to this record.

Abstract & Overview

Among all the stromal cells that present in the tumor microenvironment, cancer-associated fibroblasts (CAFs) are one of the most abundant and critical components of the tumor mesenchyme, which not only provide physical support for tumor cells but also play a key role in promoting and retarding tumorigenesis in a context-dependent manner. CAFs have also been involved in the modulation of many components of the immune system, and recent studies have revealed their roles in immune evasion and poor responses to cancer immunotherapy. In this review, we describe our current understanding of the tumorigenic significance, origin, and heterogeneity of CAFs, as well as the roles of different CAFs subtypes in distinct immune cell types. More importantly, we highlight potential therapeutic strategies that target CAFs to unleash the immune system against the tumor.

Cite this record

Tongyan Liu, Chencheng Han, Siwei Wang, Panqi Fang, Zhifei Ma, Lin Xu, et al. (2019). Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. Journal of Hematology & Oncology, 12(1), 86–86. https://doi.org/10.1186/s13045-019-0770-1

Copy in another style

Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., & Yin, R. H. (2019). Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. Journal of Hematology & Oncology, 12(1), 86–86. https://doi.org/10.1186/s13045-019-0770-1
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.